Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Magill

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Oncology|June 1, 1982
Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinomaP P Sordillo, G B Magill
Journal of Surgical Oncology|January 1, 1981
An unusual presentation of malignant mesothelioma: the incidental finding of tumor in the hernia sac during herniorrhaphyJ Brenner, P P Sordillo, G B Magill
Medical and Pediatric Oncology|January 1, 1981
Malignant mesothelioma in children: report of seven cases and review of the literatureJ Brenner, P P Sordillo, G B Magill
American Journal of Clinical Oncology|August 1, 1985
Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomasP P Sordillo, G B Magill, S Welt
Clinical Oncology|September 1, 1981
Seventeen year survival in a patient with malignant peritoneal mesotheliomaJ Brenner, P P Sordillo, G B Magill
Journal of Clinical Pharmacology|March 1, 1989
The influence of antineoplastic chemotherapy on antipyrine metabolism in manP S Wissel, P Sordillo, G B Magill
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of pyrazofurin in patients with metastatic sarcomaR J Gralla, P P Sordillo, G B Magill
Journal of Surgical Oncology|June 1, 1990
Central venous catheter complications in sarcoma patients receiving adjuvant chemotherapyR J Israel, G B Magill, M F Brennan
Cancer Treatment Reports|May 1, 1981
Chlorozotocin: phase II evaluation in patients with advanced sarcomasP P Sordillo, G B Magill, R J Gralla
Cancer Treatment Reports|May 1, 1981
Phase II evaluation of vindesine sulfate in patients with advanced sarcomasP P Sordillo, G B Magill, R J Gralla
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Oncology|June 1, 1982
Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinomaP P Sordillo, G B Magill
Journal of Surgical Oncology|January 1, 1981
An unusual presentation of malignant mesothelioma: the incidental finding of tumor in the hernia sac during herniorrhaphyJ Brenner, P P Sordillo, G B Magill
Medical and Pediatric Oncology|January 1, 1981
Malignant mesothelioma in children: report of seven cases and review of the literatureJ Brenner, P P Sordillo, G B Magill
American Journal of Clinical Oncology|August 1, 1985
Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomasP P Sordillo, G B Magill, S Welt
Clinical Oncology|September 1, 1981
Seventeen year survival in a patient with malignant peritoneal mesotheliomaJ Brenner, P P Sordillo, G B Magill
Journal of Clinical Pharmacology|March 1, 1989
The influence of antineoplastic chemotherapy on antipyrine metabolism in manP S Wissel, P Sordillo, G B Magill
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of pyrazofurin in patients with metastatic sarcomaR J Gralla, P P Sordillo, G B Magill
Journal of Surgical Oncology|June 1, 1990
Central venous catheter complications in sarcoma patients receiving adjuvant chemotherapyR J Israel, G B Magill, M F Brennan
Cancer Treatment Reports|May 1, 1981
Chlorozotocin: phase II evaluation in patients with advanced sarcomasP P Sordillo, G B Magill, R J Gralla
Cancer Treatment Reports|May 1, 1981
Phase II evaluation of vindesine sulfate in patients with advanced sarcomasP P Sordillo, G B Magill, R J Gralla
Pageof 5